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Abstract 
Background: In this study, we evaluated the existence of blaNDM ,  blaDIM, blaIMP, blaVIM, blaCTX-M-15 beta-
lactamase  genes among Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from 
hospitalized patients. 
Materials and Methods: From June 2013 to May 2014, thirty-four nonduplicate nonconsecutive isolates of A. 
baumannii and P. aeruginosa were isolated from blood, respiratory tract, wound, sputum and urine samples of 
patients from hospitalized in two hospitals in Tehran, Iran. Antibiotic susceptibility test was performed by 
Kirby-Bauer disc diffusion method according to CLSI guidelines. In this study, the frequency of MBL 
(metallo-beta-lactamase) producers was evaluated by CDDT (Combined disk diffusion test) and prevalence of 
blaNDM, blaDIM, blaIMP, blaVIM and blaCTX-M-15  genes were evaluated  by PCR and sequencing methods among P. 
aeruginosa and  A. baumannii strains isolated from  hospitalized patient of Tehran during 2013 -2014 years. 
Results: Of thirty-four non-fermenter isolates, 24 (70.58%) P. aeruginosa and 10 (29.41%) as A. baumannii 
were isolated and identified. High rate of resistance to common antibiotics were detected specially among A. 
baumannii isolates that showed 100% resistance to 4 of tested antibiotics. The CDDT results reveal that 4 
(16.66%) of the P. aeruginosa isolates and 1 (10%) of the A.baumannii were positive for production of 
MBLs. The prevalence of blaCTX-M-15 gene among 10 A. baumannii isolates was 4 (40%), and for IMP-1, 2 
(20%). The 𝑏𝑙𝑎OXA-51 has been investigated and was detected in all A. baumannii isolates. Also the 
prevalence of blaCTX-M-15 gene among 24 P.aeruginosa isolates was 11 (45.83%), and for IMP-1, 3(12.5%). 
Fortunately, 𝑏𝑙𝑎NDM, blaVIM, blaDIM gene was not detected in all isolates. 
Conclusion: The detection of MBL-producing A. baumannii and P. aeruginosa strains detected in this research 
is of great concern and highlights the need of infection control measures, including antimicrobial management 
and prompt detection of beta-lactamase-producing isolates. 
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Multidrug-resistant microorganisms have emerged as 
the causes of nosocomial infections worldwide. In 
recent years, pandrug-resistant (PDR) bacterial 
strains, which are resistant to all antimicrobial agents 
except for the tigecycline, colistin, and extensively 
drug-resistant (XDR) bacterial strains that are 
resistant to all antibiotics, have been isolated from 
patients with nosocomial infections. These bacterial 




 A. Bunny and P. aeruginosa are common 
opportunistic gram-negative bacteria related to 
hospital-acquired infections with high morbidity and 
mortality, particularly among patients with 
immunodeficiency disorders
2
. Currently, increasing 
antimicrobial resistance among A. baumannii and P. 
aeruginosa strains have been considered to be a 
major concern worldwide (3). Resistance to beta-
lactam antibiotics is more prevalent among 
opportunistic non-fermentative bacteria such as A. 
baumannii and P. aeruginosa. The most common  
mechanism of resistance to beta-lactam antibiotics is 
the production of beta-lactamase enzymes, including 
enzymes of Ambler classes A, D and B, with the 
corresponding genes often been associated with 
mobile genetic elements such as plasmid
4
. Extended-
Spectrum-beta-Lactamases (ESBLs) are among the 
Ambler Class A beta-lactamases, which can degrade 
monobactams and cephalosporins but not 
carbapenems or cephamycins. Metallo-beta-
lactamases (MBLs) that are in Ambler class B and 
metal ion associated enzymes and can hydrolyze a 
wide range of beta-lactam antibiotics even 
carbapenems
5
. Furthermore, the MBL-encoding 
genes located on integrons can be disseminated 
easily from one bacterium to another. Many MBLs 
have been found in P. aeruginosa and A. baumannii, 
including Verona integron-encoded metallo-beta-
lactamases (VIM), Imipenemase (IMP), Seoul 
imipenemase (SIM), Japan, Kyorin University 
Hospital Imipenemase (KHM), German imipenemase 
(GIM), New-Delhi metallo-beta-lactamase-(NDM-1) 
and Australian Imipenemase (AIM)
6,7
. Also, there are 
various genotypes of ESBLs such as blaSHV, blaTEM, 
and blaCTX-M types (8). Therefore the aim of this study 
was to determine the frequency of blaDIM, NDM, 
IMP, VIM and CTX-M-15 genes among P. 
aeruginosa and A. baumannii isolates from 
hospitalized patients in two Hospitals, Tehran, Iran 
during the years 2013 and 2014. 
Methods 
Bacterial Identificationc From June 2013 to May 
2014, thirty-four nonduplicate nonconsecutive isolates 
of A. baumannii and P.aeruginosa were isolated from 
blood, respiratory tract, wound, sputum and urine 
samples of patients from hospitalized in two hospitals 
in Tehran, Iran. From 10 isolates of A.baumannii 1 
(10%) were isolated from blood, 1 (10%) from 
sputum, 2 (20%) from trachea, 2 (20%) from bronsh, 2 
(20%) from wound, 2 (20%) from urine. 34 isolates of  
P. aeruginosa  were collected from blood 6 (25%), 
from sputum1 (4.16%), from trachea 4 (16.66%), from 
bronsh 4 (16.66%), from wound 9 (37.5%). The 
isolates were identified by conventional biochemical 
methods
9
 and also A. baumannii isolates were 
confirmed by blaOXA-51 gene PCR. 
Antimicrobial susceptibility testing: The Kirby-
Bauer disk diffusion method on Mueller Hinton agar 
(Merck, Germany) was performed based on Clinical 
and Laboratory Standards Institute (CLSI) guidelines 
2012
9
 Antimicrobial susceptibility tests was 
accomplished on imipenem  (IPM: 10μg), meropenem 
(MEM: 10μg), ceftazidime (CAZ: 30μg), cefotaxime 
(CTX: 30μg),  amikacin (AK: 30μg), 
piperacillin/Tazobactam (PTZ: 100/10 μg), 
ciprofloxacin (CIP: 5 μg), cefepime (FEP: 30 μg), 
ceftriaxone (CRO: 30μg), aztreonam (ATM: 30μg) , 
gentamicin (GEN: 10μg), colistin sulphate (CT,10 𝜇g), 
tetracycline (TE, 10 𝜇g), piperacillin (PIP, 100 𝜇g) and 
ciprofloxacin (CIP: 5 𝜇g). All purchased from Mast 
Group, Merseyside, UK. P. aeruginosa ATCC27853 
and E. coli ATCC25922 were used as control strains. 
Minimum Inhibitory Concentration (MIC): Strains 
found resistant to IPM and CAZ by disk diffusion test 
were re-checked using broth microdilution broth 
method according to the guidelines of CLSI 2012
10
. 
MIC for Meropenem (Jaberebne Hayyan Co), 
ceftazidime (Jaberebne Hayyan Co) and ciprofloxacin 
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(GLAXO England Co) ranging from 0.5 μg/ml to 
256 μg/ml was tested. Also, P. aeruginosa ATCC 
27853 was used as the control strain. 
Phenotypic Detection of MBL: Combined disk 
diffusion test (CDDT) was performed for 
identification of MBLs by imipenem and meropenem 
(Mast Group, Merseyside, UK) alone and in 
combination with EDTA. An increase in zone 
diameter of ≥7mm around the Imipenem+EDTA and 
Meropenem+EDTA disks compared to that of 
Imipenem and Meropenem disks alone, respectively, 
was considered positive for MBL production
11
. 
PCR and Sequencing: Total DNA was extracted by 
phenol-chloroform method (2). PCR method was 
used for screening of the blaIMP, blaVIM, blaDIM and 
blaNDM genes. The primers and PCR programs used 
in this study were as previously described (10). The 
predictive PCR product sizes were: 232 bp for (IMP-
F and IMP-R), 390bp for (VIM-F and R), 621bp for 
(NDM-F and R), 699bp for (DIM-F and R), 
respectively
12
. Amplification for blaCTX-M-15 gene was 
performed with primers CTX-M-15-F (5′-
GCGATGGGCAGTACCAGTAA-3′) and CTX-M-
15-R (5′-TTACCCAGCGTCAGATTCCG -3′). 
Amplification was carried out with the following 
thermal cycling conditions: 5 min at 94°C and 36 
cycles of amplification consisting of 1 min at 94°C, 1 
min at 55°C, and 1 min at 72°C, with 5 min at 72°C 
for the final extension. PCR product bands were 
analyzed after electrophoresis in a 1% agarose gel at 
95 V for 45 min in 1X TBE containing Ethidium 
Bromide under UV irradiation. The PCR purification 
kit (Bioneer Co., Korea) was used to purify PCR 
products and sequencing was performed by the 
Bioneer Company (Korea). The nucleotide sequences 
were analyzed with Chromas 1.45 software and 
BLAST in NCBI. 
Results 
Totally, 34 non-fermenter gram-negative bacteria were 
isolated from two hospitals in Tehran. Of the 34 non-
fermenter isolates, 24 (70.58%) were identified as P. 
aeruginosa and 10 (29.41%) as A. baumannii. from 10 
isolates of A. baumannii 1 (10%) were isolated from 
blood, 1 (10%) from sputum, 2 (20%) from trachea, 2 
(20%) from bronsh, 2 (20%) from wound, 2 (20) from 
urine also 34 of  P. aeruginosa  isolates were collected 
from blood 6 (25%), from sputum 1 (4.16%), from 
trachea 4 (16.66%), from bronsh 4 (16.66%), from 
wound 9 (37.5%). The CDDT results reveal that 4 
(16.66%) of the P. aeruginosa isolates and 1 (10%) of 
the A. baumannii were positive for production of 
MBLs. The antimicrobial susceptibility test results for 
A. baumannii are presented in Table 1 and 
antimicrobial susceptibility results for P. aeruginosa 
are presented in Table 2. The MICs of CAZ, IMP, CIP 
for P. aeruginosa and A. baumannii are presented in 
Table 1: Antimicrobial susceptibility test results of 10 isolated A. baumannii. 
Antibiotic Resistant, number (%) Intermediate, number (%) Sensitive, number (%) 
Piperacillin 10 (100) 0 (0.0) 0 (0.0) 
Piperacillin/tazobactam 9 (90) 1 (10) 0 (0.0) 
Ceftazidime 10 (100) 0 (0.0) 0 (0.0) 
Cefepime 9 (90) 0 (0.0) 1 (10) 
Cefotaxime 10 (100) 0 (0.0) 0 (0.0) 
Ceftriaxone 9 (90) 1 (10) 0 (0.0) 
Imipenem 6 (60) 1 (10) 3 (30) 
Meropenem 5 (50) 1 (10) 4 (40) 
Colistin 0 (0.0) 0 (0.0) 10 (100) 
Gentamicin 5 (50) 1 (10) 4 (40) 
Amikacin 5 (50) 2 (20) 3 (30) 
Ciprofloxacin 10 (100) 0 (0.0) 0 (0.0) 
Tetracycline 9 (90) 0 (0.0) 1 (10) 
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Table 3. 
The prevalence of blaCTX-M-15 gene among 10 A. 
baumannii isolates was 4 (40%), and for IMP-1, 2 
(20%). The 𝑏𝑙𝑎OXA-51 has been investigated and was 
detected in all A. baumannii isolates. Also the 
prevalence of blaCTX-M-15 gene among 24 P. 
aeruginosa isolates was 11 (45.83%), and for IMP-1, 
3 (12.5%). Fortunately, 𝑏𝑙𝑎NDM, blaVIM, blaDIM gene 
was not detected in all isolates. 
Discussion 
A. baumannii and P. aeruginosa is responsible for 
nosocomial infections
13
 and reported by different 
global studies including Iran. At present, 
carbapenems such as imipenem or meropenem 
commonly represents main resources for treatment of 
infections caused by Gram-negative opportunistic 
bacteria such as P. aeruginosa and A. baumannii 
strains
14
. Existence of both intrinsic and acquired 
resistant against antibiotics among these bacteria 
especially P. aeruginosa and A. baumannii strains 
make it a general challenge.  
Based on different studies, it is clear that emergence of 
resistant P. aeruginosa and A. baumannii strains is 
increasing worldwide. In this research, the resistance 
rates of P. aeruginosa strains to most experienced 
antibiotics were high and the resistance of A. 
baumannii strains to 4 out of 10 tested antibiotics was 
above 100%. These results are in accordance with 
those of other studies conducted by Fallah et al, 
Shahcheraghi et al., Hashemi et al., and Hakemi vala 
et al. in Tehran
2,11,15
. The most mechanism of       
resistance to beta-lactam-antibiotics is the production 
of β-lactamases. Due to the wide extending spreading 
of the MBLs, potent to Decomposition carbapenems 
activity and resistance to inhibitors, these enzymes can 
confer resistance to almost all beta-lactams
15
. The 
CDDT results reveal that 4 (16.66%) of the P. 
aeruginosa strains and 1 (10%) of the A. baumannii 
were positive for production of MBLs.  
Usually, restriction in phenotypic methods urges 
Table 2: Antimicrobial susceptibility test results of 24 isolated P.aeruginosa. 
Antibiotic Resistant, number (%) Intermediate, number (%) Sensitive, number (%) 
Piperacillin 10 (41.66) 4 (16.66) 10 (41.66) 
Piperacillin/tazobactam 7 (29.16) 5 (20.83) 11 (45.83) 
Ceftazidime 16 (66.66) 2 (8.33) 6 (25) 
Cefepime 13 (54.16) 5 (20.83) 6 (25) 
Aztreonam 17 (70.83) 2 (8.33) 5 (20.83) 
Imipenem 8 (33.33) 1 (4.16) 15 (62.5) 
Meropenem 9 (37.5) 0 (0.0) 15 (62.5) 
Colistin 4 (16.66) 0 (0.0) 20 (83.33) 
Gentamicin 15 (62.5) 1 (4.16) 8 (33.33) 
Amikacin 14 (58.33) 0 (0.0) 10 (41.66) 
Ciprofloxacin 12 (50) 4 (16.66) 8 (33.33) 
 
 Table 3: Minimum Inhibitory Concentration (MIC) of ceftazidime, imipenem and Ciprofloxacin for P. aeruginosa and 
A. baumannii. 













Ceftazidime 32 256 2-256 128 256 64-256 
Meropenem 2 32 2-256 32 128 2-256 
Ciprofloxacin 4 32 2-64 64 128 32-256 
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researchers to confirm by molecular methods. In the 
other hand, there are different genes which are coded 
beta-lactamses
7
.  Among MBL genes, IMP gene is 
more important, specially in Iran
11
, however, its first 
report was from Japan country at 1980.The other 
gene is blaVIM, which was detected before from 
Ahwaz another city of Iran
7
. In our study, IMP gene 
was identificated only in 3 (12.5%) of P. aeruginosa 
strain by PCR and sequencing methods. In the other 
hand, this gene was identificated among 2 (20%) of  
A. baumannii strains in this study. Also, blaVIM gene 
was not detected among neither P. aeruginosa strains 
nor A. baumannii strains. These results are in contrast 
to other studies from different cities of Iran which 
reported 11.43% of Tehran isolated P. aeruginosa 
strains and 19.51% of Ahwaz P. aeruginosa isolates 
had VIM gene
11
. Also Saderi et al. reported 94% of 
P. aeruginosa isolates from Tehran were identified as 
MBL producer and carried the blaVIM-2 gene
16
. While 
Fallah et al. at 2012 showed that P. aeruginosa 
isolates from burn patients similar to our study-only 
had blaIMP gene
11
. Fortunately, 𝑏𝑙𝑎ND, blaVIM, blaDIM 
gene was not detected in all isolates. The high rate of 
ESBL prevalence in Iran and its widespread 
dissemination is a cause worry. However, in this 
study the existence of blaCTX-M-15 was detected in 11 
(45.83%) of P. aeruginosa and 4 (40%) of MBL-
producing A. baumanii isolates, respectively, this is 
worrisome, especially in Iran where the ESBL 
prevalence is very high. 
Conclusion 
The existence of MBL-producing isolates and their 
isolation from life-threatening infections such as 
hospitalized patients, is increasing at an alarming rate 
worldwide. Intense pressure for usage of 
antimicrobial antibiotics in hospitals, resulting in 
eradication of normal flora and may be a situation of 
multidrug resistance isolates substitution. It was 
shown in this research that MBL-producing P. 
aeruginosa and A. baummanni strains are emerging 
threat in hospitals and should be supervised by 
implementation of timely detection and strict 
isolation methods that will help to reduce their severe 
outcomes and mortality rate in these patients. 
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